Journey Medical (DERM) Receivables - Net: 2020-2025
Historic Receivables - Net for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to $18.0 million.
- Journey Medical's Receivables - Net rose 68.52% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year increase of 68.52%. This contributed to the annual value of $10.2 million for FY2024, which is 32.79% down from last year.
- According to the latest figures from Q3 2025, Journey Medical's Receivables - Net is $18.0 million, which was up 14.95% from $15.6 million recorded in Q2 2025.
- Journey Medical's 5-year Receivables - Net high stood at $31.7 million for Q3 2021, and its period low was $8.0 million during Q3 2023.
- Moreover, its 3-year median value for Receivables - Net was $15.2 million (2023), whereas its average is $14.6 million.
- Its Receivables - Net has fluctuated over the past 5 years, first plummeted by 72.00% in 2023, then soared by 83.95% in 2025.
- Journey Medical's Receivables - Net (Quarterly) stood at $23.1 million in 2021, then climbed by 22.05% to $28.2 million in 2022, then crashed by 46.04% to $15.2 million in 2023, then tumbled by 32.79% to $10.2 million in 2024, then surged by 68.52% to $18.0 million in 2025.
- Its Receivables - Net stands at $18.0 million for Q3 2025, versus $15.6 million for Q2 2025 and $18.0 million for Q1 2025.